Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women
- 1 July 1995
- journal article
- Published by Elsevier in The Lancet
- Vol. 346 (8967) , 89-90
- https://doi.org/10.1016/s0140-6736(95)92114-1
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction.Circulation, 1994
- Hormone Replacement Therapy and the Cardiovascular SystemDrugs, 1994
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Treatmetn of mild to moderate hypertension with or without the converting enzyme inhibitor enalaprilThe American Journal of Medicine, 1987